Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Here's Why Doximity Dropped 22% in August
08:16am, Thursday, 08'th Sep 2022
The telehealth stock's growth outlook scared investors.
3 Tech Stocks Down 50% or More to Buy Now
07:00am, Sunday, 28'th Aug 2022
These three companies are down big, but don't overlook their potential after crashing.
AMN vs. DOCS: Which Stock Is the Better Value Option?
12:48pm, Thursday, 25'th Aug 2022
AMN vs. DOCS: Which Stock Is the Better Value Option?
Doximity Appears Well-Positioned But Shares May Be Fully Valued Here
01:40pm, Thursday, 11'th Aug 2022
Doximity went public in June 2021, raising approximately $606 million in gross proceeds in a U.S. IPO. The firm operates a digital collaboration and communication platform for physicians in the United
3 Healthcare Stocks With High Profit Margins
05:13am, Wednesday, 10'th Aug 2022
If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.
BLCO vs. DOCS: Which Stock Should Value Investors Buy Now?
12:47pm, Tuesday, 09'th Aug 2022
BLCO vs. DOCS: Which Stock Is the Better Value Option?
We were surprised by macro headwinds, seems healthcare isn't immune, says Doximity CEO
01:13pm, Friday, 05'th Aug 2022
Jeff Tangney, Doximity CEO, joins 'TechCheck' to discuss the issues with the company's quarterly earnings results, Doximity's plans for diversification and Tangney's thoughts on tele-health prospects
Doximity, Inc. (DOCS) CEO Jeff Tangney on Q1 2023 Results - Earnings Call Transcript
10:44pm, Thursday, 04'th Aug 2022
Doximity, Inc. (NYSE:DOCS ) Q1 2023 Results Conference Call August 4, 2022 5:00 PM ET Company Participants Perry Gold - Head, IR Jeff Tangney - Co-Founder and CEO Dr. Nate Gross - Co-Founder and CSO A
3 Best Telehealth Stocks To Buy Now
07:00am, Tuesday, 19'th Jul 2022
The best telehealth stocks are undervalued after an abrupt sell-off. There are a few names such as TDOC, DOCS and HUM that stand out.
SVB Leerink Sees 'Cheaper Way' To Pharma Digital Marketing With This Stock
03:23pm, Friday, 15'th Jul 2022
SVB Leerink initiated coverage on OptimizeRx Corporation (NASDAQ: OPRX) with a buy rating and a price target of $38, implying an upside of 36%. The analysts say OptimizeRx is the largest EHR-embed
AVTR or DOCS: Which Is the Better Value Stock Right Now?
12:58pm, Friday, 15'th Jul 2022
AVTR vs. DOCS: Which Stock Is the Better Value Option?
Doximity to Release Fiscal 2023 First Quarter Results on August 4, 2022
04:01pm, Thursday, 14'th Jul 2022
SAN FRANCISCO , July 14, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its first
Is Doximity a Buy?
11:15am, Thursday, 14'th Jul 2022
The decline in share price may not be all that surprising given Doximity's egregious valuation last year.
Doximity: A Wonderful Business At A Very Fair Price
03:36pm, Thursday, 07'th Jul 2022
Doximity is the leading professional networking platform for US healthcare professionals. The company has more than 80% of US physicians on its platform.
1 Under-the-Radar Growth Stock to Buy in July
11:45am, Thursday, 07'th Jul 2022
This platform for medical professionals is worth a closer look.
